“…By contrast, the expression of markers related to M2 macrophage activation, such as CD16, CD163, MerTK, CD206, AMAC1 and CD200R1 [23][24][25][26][27], was upregulated in cmMTB-conditioned cells ( Figure 1B, Supplementary information, Figure S1B). Similarly, the expression of CCR2 and CCR5 chemokine receptors was higher in the presence of cmMTB, supporting the acquisition of the M2 program (Supplementary information, Figure S1C) [28,29]. More precisely, the expression of M2 markers was specifically augmented within CD16 + population compared with the CD16 − counterpart, with a higher increase of CD163 and CD206 upon cmMTB treatment monocytes ( Figure 1C).…”